These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Characterization of the anaemia of chronic renal failure and the mode of its correction by a preparation of human erythropoietin (r-HuEPO). An investigation of the pharmacokinetics of intravenous erythropoietin and its effects on erythrokinetics. Cotes PM, Pippard MJ, Reid CD, Winearls CG, Oliver DO, Royston JP. Q J Med; 1989 Feb; 70(262):113-37. PubMed ID: 2594953 [Abstract] [Full Text] [Related]
16. Randomized study of darbepoetin alfa and recombinant human erythropoietin for treatment of renal anemia in chronic renal failure patients receiving peritoneal dialysis. Li WY, Chu TS, Huang JW, Wu MS, Wu KD. J Formos Med Assoc; 2008 Nov; 107(11):843-50. PubMed ID: 18971153 [Abstract] [Full Text] [Related]
19. Weekly subcutaneous recombinant human erythropoietin corrects anemia of progressive renal failure. Zappacosta AR, Perras ST, Bell A. Am J Med; 1991 Sep; 91(3):229-32. PubMed ID: 1892142 [Abstract] [Full Text] [Related]
20. [Human recombinant erythropoietin in treatment of uremic anemia in children with continual ambulatory peritoneal dialysis]. Litwin M, Boguszewska-Baczkowska A, Jelonek A. Pol Tyg Lek; 1991 Sep; 49(6-7):135-6. PubMed ID: 8090665 [Abstract] [Full Text] [Related] Page: [Next] [New Search]